Ivica Cerina

Bio

Dr. Cerina is a Partner of NGN Capital. Ivica Cerina, Ph.D. joined NGN Capital in 2005 from DyoDelta Biosciences Ltd. where he was VP Venture Financing & Business Development. Prior to that, he gained 6 years of venture capital experience at TVM - a leading German-U.S. venture firm with over €1.2B under management - where he was responsible for deal sourcing, due diligence, deal support and business development. At TVM he worked with the partners on existing portfolio companies and new transactions (e.g. Addex, Jerini, SelectX, Direvo) and established a strong international network with leading venture firms, investment banks, biotech & pharma companies. Prior to TVM, Dr. Cerina worked as a consultant advising start-ups and small and mid-size entities on financing and business strategy. Dr. Cerina studied Biochemistry at the J.W.Goethe University in Frankfurt and performed his doctorate thesis at the Hemostasis Research Unit of the Max-Planck-Institute for Physiological & Clinical Research in Bad Nauheim. Dr. Cerina currently serves on the Board of Directors of NaniRx Therapeutics and holds an observer seat on the board of Vivaldi Biosciences.